Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial

Anne M. Horgan, Bostjan Seruga, Greg R. Pond, Shabbir M. Alibhai, Eitan Amir, Ronald De Wit, Mario A. Eisenberger, Ian F. Tannock

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences